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knee joints with TGF-beta alone or TGF-beta + BMP-2 three times
on alternate days (200 ng/knee) and measured proteoglycan (PG)
content in cartilage.
In addition, we evaluated the signiﬁcance of a shift in Smad
balance in human OA cartilage by exposure of the explants to
TGF-beta or a combination of TGF-beta + ALK5 inhibitor SB-
505124. RNA was isolated for Q-PCR analysis.
Results: Overexpression of BMP-2 in murine knee joints, thereby
stimulating the Smad1/5/8 signaling route, decreased Smad2/3P
expression in cartilage and increased staining of VDIPEN and
NITEGE epitopes (MMP- and ADAMTS-mediated cartilage break-
down respectively). In vitro, chondrocyte exposure to BMP-2 re-
sulted in up regulation of aggrecan, collagen type II, collagen type
X and MMP13 expression. Thus, elevating Smad1/5/8 signaling is
associated with concomitant reduction of Smad2/3 signaling and
OA-like alterations.
After in vivo exposure to TGF-beta, a mild decrease in PG content
(8%) in tibial cartilage was found. However, combining TGF-beta
with BMP-2 resulted in 21% decrease in PG content. PG staining
was lost in the deep zones of tibial cartilage, just above the
tide-mark.
To investigate the effect of reduced Smad2/3 activation on overall
Smad signaling we blocked ALK5 activity (Smad2/3 route) in
TGF-beta activated chondrocytes with SB-505124. Besides the
expected decrease in Smad2/3P, Smad1/5/8P was enhanced,
thereby contributing to a shift in Smad signaling balance.
Human OA cartilage exposure to TGF-beta inhibited MMP-13
expression. This inhibition was totally blocked by SB-505124. This
indicates that in chondrocytes inhibition of Smad2/3P activation
enhances MMP-13 expression.
Conclusions: Our data indicate that the Smad2/3 and Smad1/5/8
balance determines chondrocyte function. Either up regulation
of the Smad1/5/8 pathway or down regulation of the Smad2/3
route, both we have observed in OA cartilage, appears associated
with increased chondrocyte MMP-13 expression. This ﬁts with
published observations that Smad1/5/8 stimulates while Smad2/3
signaling blocks chondrocyte terminal differentiation.
These results indicate that factors changing the balance to dom-
inant Smad1/5/8 signaling, for instance changes in TGF beta
superfamily ligands or receptors, will affect chondrocyte differ-
entiation and MMP-13 expression and might play a role in OA
development.
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THE CHROMATIN MODIFYING ENZYME SIRT1 REPRESSES
THE ARTHRITIS-ASSOCIATED MMP13 EXPRESSION IN
HUMAN ARTICULAR CHONDROCYTES
E.-J. Lee, M. Dvir-Ginzberg, O. Gabay, V. Gagarina, D.J. Hall
NIH, Bethesda, MD
Purpose: Osteoarthritis (OA) is a degenerative joint disease of
the articular cartilage resulting in the depletion of collagens and
proteoglycans due in part to accelerated turnover and inadequate
repair. Maintenance of healthy articular cartilage in human adults
relies on the optimal expression of a number of unique extracel-
lular matrix genes, such as aggrecan and collagen type II, by
the chondrocytes in this tissue. MMP13 is a proteolytic enzyme
that degrades the extracellular matrix, including the cartilage-
speciﬁc component, type II collagen. MMP13 is thought to play
a critical role in cartilage degradation in OA. SirT1 is an NAD-
dependent histone deacetylase that lengthens organism life span
by reducing the severity of age-related diseases. Since OA is an
age-associated disease, it is pertinent to explore the role SirT1
plays in MMP expression in human adult chondrocytes from OA
patients. Here we show that MMP13 expression and activity is
downregulated by SirT1 in human chondrocytes.
Methods: Human chondrocytes (hChs) were isolated from the
knees of osteoarthritic patients undergoing total knee arthroplasty,
supplied by the National Disease Research Interchange (NDRI),
Philadelphia, PA. Cells were cultured in monolayer. Chondrocyte
transfections were carried out using the Amaxa Nucleofector tech-
nology. Cells were processed for protein or RNA extraction followed
by immunoblotting or RT-PCR according to standard procedures,
using the indicated antibodies and primer pairs.
Results: MMP13 levels were assessed in OA human chondro-
cytes stably expressing SirT1. Immunoblot assays conﬁrmed SirT1
overexpression and an increase in SirT1 activity in cells express-
ing wild type SirT1 indicates that the ectopic SirT1 is active
within these chondrocytes. The SirT1-expressing cells display sig-
niﬁcantly reduced MMP13 RNA and protein levels compared to
control cell lines. The activity of MMP13 was also decreased
in SirT1-overexpressing cells. These results demonstrate that
MMP13 gene expression is suppressed by SirT1. Treatment of
chondrocytes with the SirT1 inhibitor nicotinamide (NAM), led to a
signiﬁcant increase in MMP13 mRNA levels and MMP13 protein
levels. When SirT1 protein levels were also reduced by SirT1
siRNA, it led to increased MMP13 expression. Treatment of cells
with IL1beta led to induction of MMP13, yet SirT1 was partially
able to block this IL1beta-mediated induction.
To explore the basis by which Sirt1 represses MMP13 transcrip-
tion, we focused on the Lef1 transcription factor, a component of
the Wnt-signaling pathway. Lef1 has been demonstrated to posi-
tively regulate MMP13 transcription in chondrocytes. We ﬁnd that
SirT1 represses LEF1 levels and as a consequence represses
transcription from Lef1 target promoters.
Conclusions: We ﬁnd that longevity factor SirT1 is a potent re-
pressor of MMP13 gene expression, an enzyme involved in joint
destruction in OA, an age-associated disease. The repression
of MMP13 occurs even in the presence of the cytokine IL1beta.
MMP13 is a critical player in joint destruction in OA. The underlying
mechanism by which SirT1 represses MMP13 appears to involve
the Lef1 transcription factor a known regulator of MMP13 tran-
scription. That Lef1 is repressed by SirT1 is consistent with recent
data indicating that Wnt/β-catenin signaling pathway is involved in
IL-1beta-mediated cartilage degeneration. Taken together, these
data show that SirT1 represses the expression of genes known to
play a critical role in the onset of cartilage pathology.
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P188 ALONE OR IN COMBINATION WITH OP-1 IS
EFFECTIVE IN REDUCING CARTILAGE DEGENERATION
AND PROMOTING CELL SURVIVAL IN THE MODEL OF
ACUTE TRAUMA TO HUMAN ANKLE CARTILAGE: THE
MECHANISM OF ACTION
S. Bajaj, K. Sampath, C. Pascual-Garrido, F. Hirschfeld,
A.A. Hakimiyan, L. Rappoport, M.A. Wimmer, T.R. Oegema Jr.,
S. Chubinskaya
Rush Univ. Med. Ctr., Chicago, IL
Purpose: There is a clear need to recognize the risk of OA follow-
ing joint injury, and to develop and implement strategies to prevent
posttraumatic OA. The main objectives of this continuing study
were to investigate the effect and understand the mechanism of
action of P188 surfactant alone or in combination with osteogenic
protein-1 (OP-1) on cartilage degeneration and cell survival in
acute trauma to human ankle cartilage.
Methods: We developed a model of open joint acute trauma in
which injury is created to human ankle cartilage ex vivo by the
application of a 4 mm cylindrical impactor with stress of 30 MPa.
This type of injury is limited to damage on the articular surface. To
investigate the effect of therapeutic interventions, sixteen normal
tali from human organ donors were impacted using a 4mm indenter
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with 600N. 8mm cartilage plugs containing the 4mm impacted core
and 4mm immediately adjacent non-impacted ring were removed
and cultured with or without P188 (8mg/ml) alone or in combination
with OP-1 (100ng/ml). For metabolic studies, tissue explants were
cultured with P188 and OP-1 for 48 hours, after which the media
were replaced with plain media contained ITS and the cultures
were continued for up to 14 days. Cell survival with live/dead assay,
apoptosis with Tunel assay and structural integrity with Safranin
O staining were assessed at days 0, 2, 7, and 14. Mechanistic
studies were undertaken in order to assess the mode of action
of P188 via its regulation of IL-6 and MAPK mediated signaling
pathways. In this part of the study, tissue explants were cultured in
the presence of P188 only for 20 min, 1 hour, and 24 hours, after
which the cells were lysed and total lysates were blotted with the
antibodies against phosphorylated and non-phosphorylated forms
of ERK, JNK, P38 kinase, Stat1, Stat3, ATF-2, and GSK3. In all
experiments the data were compared to the corresponding non-
treated impacted control and to normal non-impacted cartilage.
Results: A single impact to human articular cartilage resulted in
cell death at the impaction site and radial progression of apoptosis
to adjacent ring. P188 alone promoted cell survival by reducing
cell death more than 2-fold (p<0.05) in the core and about 30%
in the ring as compared to all untreated controls. It also inhibited
expansion of apoptosis in the ring especially within ﬁrst 7 days
post impaction (7.5% Tunel-positive cells vs 46% in the untreated
control; p<0.01). Effect of OP-1 on P188-mediated responses
was primarily accumulated by day 14, where under the combined
treatment there was a tendency towards enhanced cell survival
and reduced apoptosis, and statistically signiﬁcant improvement
of histological appearance of cartilage in both core and ring
areas (P<0.04 and P<0.01 respectively) in comparison to the
corresponding areas treated with P188 alone. We also found that
injury to human cartilage resulted in the activation of IL-6 signaling,
stress related pathway, namely P38, and apoptosis related GSK3
activation. We identiﬁed here that P188 mediated its protective
effects on cell survival and cartilage integrity through the inhibition
of phosphorylation of MAPK/ERK, JNK, and p38 and attenuation
of IL-6 signaling via inhibition of Stat1 and Stat3; furthermore,
phosphorylation of ATF2 (downstream in P38 pathway) was also
affected. In addition, P188 was able to inhibit phosphorylation of
GSK3.
Conclusions: Observed results identiﬁed novel mechanisms of
P188 action and suggest its therapeutic potential alone or in
combination with anabolic agent OP-1 in preventing progressive
cartilage degeneration and the development of post-traumatic OA.
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CHROMATIN PROTEIN HMGB2 REGULATES ARTICULAR
CARTILAGE SURFACE MAINTENANCE VIA BETA-CATENIN
PATHWAYS
N. Taniguchi, B. Carames, M. Lotz
The Scripps Res. Inst., La Jolla, CA
Purpose: The superﬁcial zone (SZ) of articular cartilage is critical
in maintaining tissue function and homeostasis and represents
the site of the earliest changes in osteoarthritis. Mechanisms that
regulate the unique phenotype of SZ chondrocytes and main-
tain SZ integrity are unknown. We have recently demonstrated
that expression of the chromatin protein HMGB2 is restricted to
the SZ of articular cartilage suggesting a transcriptional network
involving HMGB2 that regulates SZ cell phenotype. This study
addresses potential interactions between HMGB2 and the Wnt/β-
catenin pathway in regulating SZ cells.
Methods: Activation Wnt/β-catenin signaling in articular cartilage
was assessed by immunostaining for galactosidase in TOPGAL
reporter mice at 3, 6, 9 and 12 months of age, and this was com-
pared with HMGB2 expression. Functional interactions of β-catenin
and HMGB2 on cyclin D1 and TOPﬂash promoters which are re-
sponsive to Wnt/β-catenin activation was examined by luciferase
assay, and molecular interactions between β-catenin, Lef-1 and
HMGB2 were examined by GST-pull down assays. Gel shift as-
says were used to determine binding speciﬁcity and interactions
of HMGB2 and Lef-1. To further test the functional signiﬁcance
of β-catenin signaling, we conditionally inactivated β-catenin in
chondrocytes isolated from β-catenin ﬂoxed mice (Ctnnb1ﬂox/ﬂox)
with adenovirus-GFP-Cre and performed apoptosis assays.
Results: We found that the Wnt/β-catenin pathway is active specif-
ically in the SZ in normal mouse knee joints and colocalizes
with HMGB2. Both, Wnt signaling and HMGB2 expression de-
crease with aging in mouse joints. Our molecular studies show
that HMGB2, Lef-1 and β-catenin form a tri-molecular complex
on a promoter containing a Lef-1 motif. This complex enhances
the binding of Lef-1 to its target sequence and potentiates tran-
scriptional activation of the Lef-1-β-catenin complex. Furthermore,
conditional deletion of β-catenin in cultured mouse chondrocytes
induced apoptosis.
Conclusions: These ﬁndings deﬁne a pathway where protein
interactions of HMGB2 and Lef-1 enhance Wnt signaling and
promote SZ chondrocyte survival. Loss of the HMGB2-Wnt sig-
naling interaction is a new mechanism in aging-related cartilage
pathology.
218
CANONICAL WNT EXPRESSION IN THE SYNOVIUM
INDUCES OA-LIKE CARTILAGE DEGENERATION
A.B. Blom1, P.L. van Lent1, H.M. van Beuningen1,
S.M. Brockbank2, F.A. van de Loo1, P.M. van der Kraan1,
P. Newham2, W.B. van den Berg1
1Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands;
2AstraZeneca, Respiratory and Inﬂammation Res. Area, Alderley
Park, Macclesﬁeld, Cheshire, United Kingdom
Purpose: In osteoarthritis (OA), cartilage damage is one of the
main pathological features. There is, however, a signiﬁcant in-
volvement of the synovium in a large proportion of OA-patients.
The mechanism through which the synovium contributes to OA
pathology is not yet known. In cartilage, it is proposed that de-
velopmental processes important in embryonic development are
reactivated. Associations have been identiﬁed of the occurrence of
OA with polymorphisms of genes from the wnt/β-catenin pathway,
a pathway that is involved in cartilage development. The aim of
the present study is to investigate the contribution of the synovium
to OA pathology via wnt signaling.
Methods: A longitudinal expression analysis was performed in
2 murine models for OA, one with clear synovial involvement,
collagenase induced (CIOA), and the spontaneous OA model
in STR/ort mice, which shows less synovial involvement. CIOA
was generated by intra-articular injection of collagenase, which
induces joint instability. Synovial expression of components of the
wnt signaling pathway was determined at several time points.
From these results, targets were selected for the generation of
adenoviral vectors to overexpress speciﬁc genes. To study the
effect of these genes on chondrocytes, human chondrocytes were
isolated from cartilage that was obtained from joint replacement
surgery. In vivo effects were determined by intra-articular injection
of the viral vectors and determining joint pathology by histology at
several time points after injection.
Results: Strong upregulation of the canonical wnts wnt16 (up to
256-fold) and wnt2b (up to 90-fold) was found in both models, al-
though stronger in CIOA. Expression in the synovium was clearly
higher compared to the cartilage. Clear intracellular accumulation
of β-catenin was found in both synovium and cartilage, which
